Thermo Fisher to Supply Genentech with RNAi Tech for Drug Studies | GenomeWeb
NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it will supply Genentech with RNAi technology for use in siRNA-based drug discovery research.
Under the agreement, Thermo Fisher Scientific will provide Genentech with siRNA design, stabilization, delivery, and related RNAi technologies from its RNAi Discovery and Therapeutic Services lab in Colorado.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.